1 Grant
2023
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
Sandey, Maninder
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R15CA277677-01), $449,910USD, 2023-02-01 -- 2026-01-31